Research and Insights

Capital ideas from the industry’s brightest minds.

In Equity Research, our award-winning analysts deliver superior investment ideas and value-added perspective for the over 650 quality growth companies they cover. Under Insights, you will find firm publications, market commentaries, and white papers from our investment banking and asset management professionals.

Healthcare analyst John Sonnier examines the role that checkpoint inhibitors are playing in immuno-oncology and the challenges facing investors in monitoring the rapidly evolving data in this space.

Barron’s discusses the growth of industrial stocks with William Blair’s Nick Heymann.

650+ companies under
          research coverage

85+ initiations in 2014

Anil Doradla on CNBCEquity research analyst Anil Doradla discusses the outlook for Blackberry in a live studio interview with anchor Andrew Ross Sorkin on CNBC’s “Squawk Box.”